These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 19383541

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS, Brown-Woodman PD, Ritchie HE.
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [Abstract] [Full Text] [Related]

  • 3. Reproductive safety studies with genistein in rats.
    McClain RM, Wolz E, Davidovich A, Edwards J, Bausch J.
    Food Chem Toxicol; 2007 Aug; 45(8):1319-32. PubMed ID: 17433519
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC, Jacobson CF, Gao F, Tassinari MS, Hurtt ME, DeSesso JM.
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F, Pino M, DeLise B, Guittin P, Barbellion S, Brunel P, Potdevin S, Bergmann B, Hofmann T, Lerman S, Clark RL.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [Abstract] [Full Text] [Related]

  • 8. Whole embryo culture and the identification of "teratogenicity".
    Scialli AR, Iannucci AR.
    Reprod Toxicol; 2010 Apr; 29(2):247-8; author reply 249-50. PubMed ID: 19883752
    [No Abstract] [Full Text] [Related]

  • 9. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F, Rohatagi S, Pino M, DeLise B, Zhang J, Nguyen M, Guittin P, Barbellion S, Brunel P, Hofmann T, Schmidt J, Wong M, Lockey P, Lerman S, Clark R.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [Abstract] [Full Text] [Related]

  • 10. Rodent whole-embryo culture as a teratogen screening method.
    Kitchin KT, Schmid BP, Sanyal MK.
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):291-301. PubMed ID: 3724303
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of maternal toxicity in lovastatin-induced developmental toxicity.
    Lankas GR, Cukierski MA, Wise LD.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Embryotoxic and teratogenic effects of the combination of bisphenol A and genistein on in vitro cultured postimplantation rat embryos.
    Xing L, Xu Y, Xiao Y, Shang L, Liu R, Wei X, Jiang J, Hao W.
    Toxicol Sci; 2010 Jun; 115(2):577-88. PubMed ID: 20299547
    [Abstract] [Full Text] [Related]

  • 16. A comparison of gene expression responses in rat whole embryo culture and in vivo: time-dependent retinoic acid-induced teratogenic response.
    Robinson JF, Verhoef A, Pennings JL, Pronk TE, Piersma AH.
    Toxicol Sci; 2012 Mar; 126(1):242-54. PubMed ID: 22262565
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A.
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.